The Rate Negotiation Index: A New Lens on Specialty-Specific Efficiency
Introduction
While medical specialties are becoming increasingly granular through advanced fellowships and subspecialty training, many share a common foundation: the standard outpatient office visit. For established patients, these encounters are billed under CPT codes 99213, 99214, and 99215, which represent varying levels of visit complexity and time. Because these codes span nearly every specialty, they create a rare opportunity for comparison in an industry where financial benchmarking is often fragmented or incomparable.
Using these common codes as a foundation, Trek Health developed the Rate Negotiation Index, a multivariate model that integrates commercial and governmental reimbursement rates, physician salary costs, malpractice exposure, and provider density. The result is a unified framework that evaluates each specialty–state combination by its relative financial efficiency and investment potential, helping healthcare operators identify where growth and consolidation may yield the greatest returns. These recommendations stem from a novel aggregation of the specialty- and state-specific reimbursement-to-salary ratio weighted for both Medicare and commercial rates and weighted to the state specific payer mix. This composite measure forms the Base Rate Negotiation Index score. The Advanced Rate Negotiation Index score builds upon it by allocating 80% weight to the base score, with 20% divided evenly to the malpractice multiplier and physician density multiplier. Together, these aspects capture both financial efficiency and operational risk.
Key Findings
While many mergers and acquisitions formulas include reimbursement and salary as factors in their assessments, Trek Health is able to integrate newly publicized commercial reimbursement data via the Transparency in Coverage ruling. Additionally, no publicly available model incorporates both malpractice and market saturation as variables. This comprehensive approach provides a multidimensional view of financial efficiency, accounting not only for revenue and cost but also for risk, scarcity, and strategic scalability.
These findings highlight pediatrics as one of the most undervalued yet opportunity-rich markets in U.S. healthcare. With relatively low physician salaries juxtaposed with relatively high commercial and governmental reimbursement rates, this specialty comes out on top for its investment potential. Compounding this, the specialty faces low malpractice exposure and widespread workforce shortages, creating a unique alignment of favorable economics and high demand. Together, these factors position pediatrics as a high-leverage investment opportunity in the evolving healthcare landscape.
Excluding pediatrics, the top specialty-state combinations include Endocrinology and Internal Medicine in Minnesota, as well as Family Medicine in Wisconsin. Further, Alaska, Minnesota, New Hampshire, North Dakota, and Wisconsin emerged as the most consistently high-ranking states across specialties by the Rate Negotiation Index, representing the nation’s most structurally advantageous markets for healthcare investment and physician network expansion.
Looking Ahead
The Rate Negotiation Index represents Trek Health’s ongoing commitment to using transparency-based data to translate market complexity into actionable strategy. As healthcare consolidation accelerates, understanding where efficiency converges with opportunity will be critical to sustainable growth. The full recommendations, rankings, and data will be available in our upcoming report, The Private Practice Playbook: Rate Negotiation Index Rankings for Specialty-Specific M&A Strategy, releasing on November 12th. Beyond just data reporting, Trek Health is building actionizable analytics driven by evidence-backed data.
For more insights or to explore how the Rate Negotiation Index can guide your organization’s strategic planning, contact Trek Health.
White Paper
From Transparency to Prediction: Quantifying the Drivers of Physician Reimbursement Variation
This analysis uses Transparency in Coverage data to model how payers behave, not just what they pay. By linking reimbursement rates to physician characteristics, we uncover the patterns behind payment variation and transform transparency data into predictive intelligence. The result: a predictive view of rate dynamics that helps stakeholders anticipate trends and negotiate with data-driven confidence.
White Paper
Reimbursement and Reality: The Economics of Breast Cancer Treatment
While breast cancer awareness efforts often focus on screening and treatment, one critical factor remains overlooked: how care is reimbursed. Payment structures shape far more than provider margins; they influence access, equity, and patient outcomes.
In this analysis of payer rates, Trek Health uses its Transparency Platform to analyze how reimbursement for breast cancer care varies across geography, commercial payer behavior, and public policy. The findings reveal a system that rewards disease burden rather than prevention which creates inequities that ripple through the entire care process.
Inside you’ll learn:
- How reimbursement rates differ dramatically by state and payer
- Why higher disease burden correlates with higher payment, but prevention does not
- What these trends mean for provider strategy, patient access, and equity
Download the full analysis to see how transparency data can help reshape breast cancer care—turning financial insight into fairer outcomes.
White Paper
The Private Practice Playbook: Rate Negotiation Index Rankings for Specialty-Specific M&A Strategy
Physician economics are shifting as private equity and independent platforms redefine the workforce landscape. Trek Health’s Rate Negotiation Index Report quantifies the return on physician labor across states and specialties in a new lens: combining commercial reimbursement, physician salary, malpractice risk, and provider density into a single metric. This data driven foundation for smarter M&A strategy identifies the most economically sustainable opportunities across the U.S. for physician recruitment and network expansion.
Introduction
While medical specialties are becoming increasingly granular through advanced fellowships and subspecialty training, many share a common foundation: the standard outpatient office visit. For established patients, these encounters are billed under CPT codes 99213, 99214, and 99215, which represent varying levels of visit complexity and time. Because these codes span nearly every specialty, they create a rare opportunity for comparison in an industry where financial benchmarking is often fragmented or incomparable.
Using these common codes as a foundation, Trek Health developed the Rate Negotiation Index, a multivariate model that integrates commercial and governmental reimbursement rates, physician salary costs, malpractice exposure, and provider density. The result is a unified framework that evaluates each specialty–state combination by its relative financial efficiency and investment potential, helping healthcare operators identify where growth and consolidation may yield the greatest returns. These recommendations stem from a novel aggregation of the specialty- and state-specific reimbursement-to-salary ratio weighted for both Medicare and commercial rates and weighted to the state specific payer mix. This composite measure forms the Base Rate Negotiation Index score. The Advanced Rate Negotiation Index score builds upon it by allocating 80% weight to the base score, with 20% divided evenly to the malpractice multiplier and physician density multiplier. Together, these aspects capture both financial efficiency and operational risk.
Key Findings
While many mergers and acquisitions formulas include reimbursement and salary as factors in their assessments, Trek Health is able to integrate newly publicized commercial reimbursement data via the Transparency in Coverage ruling. Additionally, no publicly available model incorporates both malpractice and market saturation as variables. This comprehensive approach provides a multidimensional view of financial efficiency, accounting not only for revenue and cost but also for risk, scarcity, and strategic scalability.
These findings highlight pediatrics as one of the most undervalued yet opportunity-rich markets in U.S. healthcare. With relatively low physician salaries juxtaposed with relatively high commercial and governmental reimbursement rates, this specialty comes out on top for its investment potential. Compounding this, the specialty faces low malpractice exposure and widespread workforce shortages, creating a unique alignment of favorable economics and high demand. Together, these factors position pediatrics as a high-leverage investment opportunity in the evolving healthcare landscape.
Excluding pediatrics, the top specialty-state combinations include Endocrinology and Internal Medicine in Minnesota, as well as Family Medicine in Wisconsin. Further, Alaska, Minnesota, New Hampshire, North Dakota, and Wisconsin emerged as the most consistently high-ranking states across specialties by the Rate Negotiation Index, representing the nation’s most structurally advantageous markets for healthcare investment and physician network expansion.
Looking Ahead
The Rate Negotiation Index represents Trek Health’s ongoing commitment to using transparency-based data to translate market complexity into actionable strategy. As healthcare consolidation accelerates, understanding where efficiency converges with opportunity will be critical to sustainable growth. The full recommendations, rankings, and data will be available in our upcoming report, The Private Practice Playbook: Rate Negotiation Index Rankings for Specialty-Specific M&A Strategy, releasing on November 12th. Beyond just data reporting, Trek Health is building actionizable analytics driven by evidence-backed data.
For more insights or to explore how the Rate Negotiation Index can guide your organization’s strategic planning, contact Trek Health.
